Filing Details
- Accession Number:
- 0001567619-22-021650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-15 16:32:20
- Reporting Period:
- 2022-12-13
- Accepted Time:
- 2022-12-15 16:32:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1626971 | Corvus Pharmaceuticals Inc. | CRVS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1031847 | Md A Richard Miller | C/O Corvus Pharmaceuticals, Inc. 863 Mitten Road, Suite 102 Burlingame CA 94010 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-13 | 50,000 | $0.74 | 1,480,119 | No | 4 | P | Indirect | By Trust |
Common Stock | Acquisiton | 2022-12-14 | 10,000 | $0.78 | 1,490,119 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
No | 4 | P | Indirect | By Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.73 to $0.7580, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Includes 35,714 shares previously held directly.
- These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7798 to $0.7899, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.